Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy

被引:159
作者
Adkins, Irena [1 ,2 ,3 ]
Fucikova, Jitka [1 ,2 ,3 ]
Garg, Abhishek D. [4 ]
Agostinis, Patrizia [4 ]
Spisek, Radek [1 ,2 ,3 ]
机构
[1] Sotio, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic
[3] Charles Univ Prague, Univ Hosp Motol, Prague, Czech Republic
[4] Univ Leuven KU Leuven, Dept Mol & Cell Biol, Cell Death Res & Therapy CDRT Unit, Leuven, Belgium
来源
ONCOIMMUNOLOGY | 2014年 / 3卷 / 12期
关键词
cancer immunotherapy; high hydrostatic pressure; hyperthermia; immunogenic cell death; ionizing irradiation; photodynamic therapy with hypericin; HIGH HYDROSTATIC-PRESSURE; DISTANT UNTREATED TUMORS; REGULATORY T-CELLS; PHOTODYNAMIC-THERAPY; DENDRITIC CELLS; CALRETICULIN EXPOSURE; ANTITUMOR IMMUNITY; ER STRESS; INTRACELLULAR HYPERTHERMIA; IONIZING IRRADIATION;
D O I
10.4161/21624011.2014.968434
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The concept of immunogenic cancer cell death (ICD), as originally observed during the treatment with several chemotherapeutics or ionizing irradiation, has revolutionized the view on the development of new anticancer therapies. ICD is defined by endoplasmic reticulum (ER) stress response, reactive oxygen species (ROS) generation, emission of danger-associated molecular patterns and induction of antitumor immunity. Here we describe known and emerging cancer cell death-inducing physical modalities, such as ionizing irradiation, ultraviolet C light, Photodynamic Therapy (PDT) with Hypericin, high hydrostatic pressure (HHP) and hyperthermia (HT), which have been shown to elicit effective antitumor immunity. We discuss the evidence of ICD induced by these modalities in cancer patients together with their applicability in immunotherapeutic protocols and anticancer vaccine development.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 125 条
[1]  
Abdul Qader Sukkurwala SA, 2014, ONCOIMMUNOLOGY, V3
[2]   Photodynamic Therapy of Cancer: An Update [J].
Agostinis, Patrizia ;
Berg, Kristian ;
Cengel, Keith A. ;
Foster, Thomas H. ;
Girotti, Albert W. ;
Gollnick, Sandra O. ;
Hahn, Stephen M. ;
Hamblin, Michael R. ;
Juzeniene, Asta ;
Kessel, David ;
Korbelik, Mladen ;
Moan, Johan ;
Mroz, Pawel ;
Nowis, Dominika ;
Piette, Jacques ;
Wilson, Brian C. ;
Golab, Jakub .
CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (04) :250-281
[3]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[4]  
Alecu M, 1998, ANTICANCER RES, V18, P4651
[5]   Ultraviolet light (UVB and UVA) induces the damage-responsive transcription factor CHOP/gadd153 in murine and human epidermis: Evidence for a mechanism specific to intact skin [J].
Anand, S ;
Chakrabarti, E ;
Kawamura, H ;
Taylor, CR ;
Maytin, EV .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (02) :323-333
[6]  
[Anonymous], 2013, Oncoimmunology, DOI DOI 10.4161/ONCI.25595
[7]   The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Criollo, Alfredo ;
Ortiz, Carla ;
Lidereau, Rosette ;
Mariette, Christophe ;
Chaput, Nathalie ;
Mira, Jean-Paul ;
Delaloge, Suzette ;
Andre, Fabrice ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
IMMUNOLOGICAL REVIEWS, 2007, 220 :47-59
[8]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[9]   Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma:: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes [J].
Audia, S. ;
Nicolas, A. ;
Cathelin, D. ;
Larmonier, N. ;
Ferrand, C. ;
Foucher, P. ;
Fanton, A. ;
Bergoin, E. ;
Maynadie, M. ;
Arnould, L. ;
Bateman, A. ;
Lorcerie, B. ;
Solary, E. ;
Chauffert, B. ;
Bonnotte, B. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 150 (03) :523-530
[10]   Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia [J].
Baba, Junko ;
Watanabe, Satoshi ;
Saida, Yu ;
Tanaka, Tomohiro ;
Miyabayashi, Takao ;
Koshio, Jun ;
Ichikawa, Kosuke ;
Nozaki, Koichiro ;
Koya, Toshiyuki ;
Deguchi, Katsuya ;
Tan, Chunrui ;
Miura, Satoru ;
Tanaka, Hiroshi ;
Tanaka, Junta ;
Kagamu, Hiroshi ;
Yoshizawa, Hirohisa ;
Nakata, Ko ;
Narita, Ichiei .
BLOOD, 2012, 120 (12) :2417-2427